Surgar, a Clermont-Ferrand, France-based company developing augmented reality solutions for minimally invasive surgery, raised €11M in Series A funding.
The round was led by Mutuelles Impact, managed by XAnge, along with Elaia Partners in partnership with MH Innov’, the corporate fund of Malakoff Humanis, Bpifrance through its Digital Venture fund, and angels including Jacques Gardette, Thierry Joubert and Pierre-Jean Lamps. Other investors including UI Investissement, Crédit Agricole Capital Innovation, D-Novafund, G-Surge Consulting, Clermont Auvergne Innovation, the CHU of Clermont-Ferrand, BNP Paribas, Crédit Agricole Centre France, and Banque Populaire Auvergne Rhône-Alpes also participated.
Led by Nicolas Bourdel, Adrien Bartoli, Michel Canis and Bertrand Le Roy, Surgar provides augmented reality software that combines the patient’s digital twin (obtained through MRI or CT scans) with the minimally invasive (laparoscopic) view in real-time to allow surgeons to visualize internal organ structures (tumors, vessels, ducts).
The company intends to use the funds to launch U-SURGAR, a software solution dedicated to female patients suffering from fibroids and adenomyosis and to finalize and commercialize L-SURGAR and K-SURGAR, aimed at treating liver and kidney cancers respectively.
FinSMEs
26/09/2024